The facility will be built in the Netherlands and will increase capacity for the company's oral medicines portfolio ...

Uniphar, a global partner to the pharmaceutical, medtech and biotech sectors, has made key appointments to its US senior ...

To open up more clinical paths for patients, HCPs need simpler search tools, better access to information and integrated ...

The rebranding of Uniphar’s US divisions aims to strengthen its integrated platform across the product life cycle ...

The summit brought together global leaders to reframe advocacy as the engine of patient-centred change, proving that connected voices can drive collective impact ...

Could it be,” he asked, “that creativity needs slack and while some companies have allowed for this, others haven’t, and this is reflected in the creativity of their customer experience approaches?” I ...

UCB, a global biopharmaceutical company, has announced the final results from its open-label extension (OLE) study evaluating ...

Novartis has reported new results from two ongoing phase 3 trials evaluating ianalumab in patients with Sjögren’s disease, ...

The expansion forms part of Lilly’s broader $50bn capital investment programme to grow its US manufacturing and production ...

The Chameleon Team has a broad range of healthcare communications expertise and experience in virtually every therapeutic category. Our specific experience is propietary to our clients but if you ...

Today, four out of five HCPs say they’re using LLMs to support clinical decision-making. As these LLM models solidify their ...

Even with those alarming numbers, the US FDA approvals of disease-modifying therapies (DMTs) such as Leqembi (lecanemab) and ...